Endometrial Thickness Dynamics and Morphologic Characteristics During Pituitary Downregulation With Antagonists in Assisted Reproductive Technology Cycles

被引:15
作者
Detti, Laura [1 ]
Yelian, Frank D. [1 ]
Kruger, Michael L. [1 ]
Diamond, Michael P. [1 ]
Puscheck, Elizabeth E. [1 ]
机构
[1] Wayne State Univ, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Detroit, MI 48201 USA
关键词
endometrial thickness; gonadotropin-releasing hormone antagonist; in vitro fertilization; outcome; sonography;
D O I
10.7863/jum.2008.27.11.1591
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective. The purpose of this study was to evaluate whether the dynamics of endometrial stripe thickness during gonadotropin-releasing hormone (GnRH) antagonist pituitary downregulation in in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles are related to implantation and pregnancy outcomes. Methods. This retrospective cohort study evaluated 115 conventional IVF/ICSI cycles. All patients underwent ovarian stimulation with gonadotropins and the GnRH antagonist ganirelix acetate. The endometrial stripe was measured transvaginally daily from the day of initial GnRH antagonist administration to the day of the human chorionic gonadotropin (hCG) trigger and then transabdominally on the day of embryo transfer We created 5 categories (0-4) of endometrial thickness variation, considering significant a daily variation of 1.5 mm. Our aim was to predict whether the endometrial thickness dynamics or morphologic characteristics were related to the duration of ovarian stimulation, duration of ganirelix use, or estradiol levels during ovarian stimulation and whether they would influence implantation and pregnancy rates. Results. No relationship was found between the duration of ovarian stimulation, duration of ganirelix use, and estradiol level (expressed as the area under the curve), and endometrial thickness dynamics or morphologic characteristics. Despite a thinner endometrial thickness in 37% of the cycles on the day of the hCG trigger compared with the beginning of GnRH antagonist stimulation, there was no correlation between endometrial dynamics and pregnancy outcomes. There was, instead, a positive relationship between a trilaminar endometrial morphologic pattern with a positive pregnancy test result, successful implantation, and ongoing pregnancy (P < .05). Conclusions. Despite a net decrease in thickness in almost 50% of cases, endometrial dynamics did not correlate with pregnancy outcomes. Conversely, a trilaminar endometrial morphologic pattern on the day of embryo transfer was positively related to pregnancy outcomes.
引用
收藏
页码:1591 / 1596
页数:6
相关论文
共 21 条
[1]   Gonadotrophin-releasing hormone antagonists for assisted conception [J].
Al-Inany, H. G. ;
Abou-Setta, A. M. ;
Aboulghar, M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03)
[2]   Changes in endometrial thickness, width, length and pattern in predicting pregnancy outcome during ovarian stimulation in in vitro fertilization [J].
Bassil, S .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (03) :258-263
[3]   Sonographic assessment of endometrial pattern and thickness in patients treated with human menopausal gonadotropins [J].
Bohrer, MK ;
Hock, DL ;
Rhoads, GG ;
Kemmann, E .
FERTILITY AND STERILITY, 1996, 66 (02) :244-247
[4]  
Borm G, 2000, HUM REPROD, V15, P1490
[5]   Histologic and functional aspects of the endometrium in the implantatory phase [J].
Bourgain, Claire ;
Devroey, Paul .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2007, 64 (03) :131-133
[6]   Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women [J].
De Geyter, C ;
Schmitter, M ;
De Geyter, M ;
Nieschlag, E ;
Holzgreve, W ;
Schneider, HPG .
FERTILITY AND STERILITY, 2000, 73 (01) :106-113
[7]   Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes [J].
Detti, Laura ;
Ambler, Dana R. ;
Yelian, Frank D. ;
Kruger, Michael L. ;
Diamond, Michael P. ;
Puscheck, Elizabeth E. .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2008, 25 (05) :177-181
[8]   Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers [J].
Duijkers, IJM ;
Klipping, C ;
Willemsen, WNP ;
Krone, D ;
Schneider, E ;
Niebch, G ;
Hermann, R .
HUMAN REPRODUCTION, 1998, 13 (09) :2392-2398
[9]  
FLEISCHER AC, 1986, FERTIL STERIL, V46, P442
[10]   Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation [J].
Fluker, M ;
Grifo, J ;
Leader, A ;
Levy, M ;
Meldrum, D ;
Muasher, SJ ;
Rinehart, J ;
Rosenwaks, Z ;
Scott, RT ;
Schoolcraft, W ;
Shapiro, DB .
FERTILITY AND STERILITY, 2001, 75 (01) :38-45